AXNX Axonics Inc.: Accounting Value per Share

Graphic logo of Axonics Modulation Technologies (AXNX)

Fierce competition in the neuromodulation segment is forcing Axonics, Inc. (AXNX) to innovate aggressively, as confirmed by the book value per share chart. Efficient implant logistics support high margins, and the current metric has reached the level of 0.17. The stable humanitarian status of its biomedical developments minimizes external risks, ensuring the company's sustainable growth regardless of global political upheavals.

Axonics Modulation Technologies - AXNX Net Assets per Share (period 07/04/2022 - 10/27/2026)
Finished products of axonics.com

The innovative potential of Axonics, Inc. (AXNX) in the field of neuromodulation and extensive R&D investments are driving the long-term asset value of the company. An analysis of the book value per share, calculated as the ratio of net equity to the number of outstanding securities, allows for an assessment of the business's actual asset backing, determining the investor's level of defensive reserve during market volatility and confirming the issuer's financial stability.

Competitors of Axonics, Inc. (AXNX)

Boston Scientific Inc (BSX) - Net Assets per Single Share|Edwards Lifesciences Inc. (EW) - Equity per Share|Accounting Value per Share ResMed Inc.|PODD (insulet.com) - Equity per Share|ZBH: Net Assets per Single Share|Net Assets per Share COO|ALGN - Net Assets per Single Share|Share Book Value NuVasive (GMED)|TMDX: Book Value per Share|Net Asset Value per Share atecspine.com ATEC|AORT: Book Value per Share|ENOV - Accounting Value per Share|Integra - Book Value per Share|Establishment Labs Inc (ESTA) - Net Assets per Share|BBNX (Beta Bionics Inc) - Book Value per Share|Book Value per Share IRMD|Net Assets per Single Share Embecta (EMBC)|Net Assets per Single Share Tandem Diabetes Care Inc (TNDM)|Book Value per Share AXGN|SIBN - Net Assets per Share|Accounting Value per Share Orthofix Medical Inc.|BVS - Share Book Value|Book Value per Share KIDS|Treace Medical Concepts Inc (TMCI) - Net Asset Value per Share|Book Value per Share Strata Critical Medical Corp (SRTA)|Equity per Share Carlsmed Medical (CARL)|RxSight, Inc. (RXST) - Accounting Value per Share|Accounting Value of a Share CLPT (clearpointneuro.com)|Stereotaxis - Net Assets per Single Share|Accounting Value per Share Neuronetics Inc. STIM|SGHT (Sight Sciences, Inc) - Book Value per Share|OBIO - Net Asset Value per Share|Book Value per Share anikatherapeutics.com|inspiremd.com (NSPR) - Equity per Share|ZJYL: Book Value per Share|Net Assets per Share Vivani|Book Value per Share XTNT (Xtant Medical Holdings)|Accounting Value per Share NeuroOne Medical Technologies Corp. (NMTC)|Book Value per Share MODD (Modular Medical, Inc.)|myomo.com - Book Value per Share|COCH - Net Assets per Single Share|Vivos Therapeutics Inc. (VVOS) - Net Assets per Single Share|Accounting Value per Share enVVeno NVNO|Sintx Technologies, Inc. (SINT) - Accounting Value of a Share|Book Value per Share TNON (Tenon Medical, Inc.)|Net Asset Value per Share LFWD|AMIX: Net Assets per Single Share|Book Value of One Share INVO Bioscience IVF|Accounting Value per Share BBLG (Bone Biologics Corporation)|Book Value per Share Biolase Inc. BIOL|Book Value per Share DYNT (Dynatronics Corp.)|FNA: Net Assets per Share|Net Assets per Single Share invobioscience.com (INVO)